DJIA 18,080.14 0.00 0.00%
NASDAQ 5,092.09 0.00 0.00%
S&P 500 2,117.69 0.00 0.00%
market minute promo

AbbVie Inc. (NYSE: ABBV)

66.07 0.00 (0.00%)

REAL-TIME: Last trade at

Extended Hours: $66.43 $0.36 (0.54%)
Quote as of (NYSE)

company name or ticker

Recent Quotes

ABBV $66.07 0.00%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $0.00
Previous Close $66.07
Daily Range $0.00 - $0.00
52-Week Range $48.95 - $70.76
Market Cap $105.3B
P/E Ratio 49.68
Dividend (Yield) $2.04 (3.1%)
Ex-Dividend Date
Dividend Pay Date
Volume 323
Average Daily Volume 11,523,946
Current FY EPS $4.20



AbbVie Inc. (ABBV) Description

AbbVie Inc. Website:

News & Commentary Rss Feed

Can You Guess Which State Won't Pay for Hepatitis C Drugs?

One state decided to take a hard line stance against Gilead's pricey hep C drugs last year. And this decision may end up turning into a huge windfall for AbbVie's rival therapy. Here's why.

3 'Safe' Biotech Picks

I Called It: What's The Take Home Message?

Trusty Horses; Tools, Pizza and Shoes: Jim Cramer's Best Blogs

Astra Deals Add To Ballooning Up-Front Payments

Are Biosimilars the Next Big Thing in Biotech?

Biosimilars could soon become a major force in biotech as multiple top-selling biologics lose patent protection. So are biosimilars the next big thing in biotech, or are they overhyped?

Merck Reports Encouraging Data on HCV Combo Candidate - Analyst Blog

AbbVie's HCV Cocktail Treatment Under FDA Priority Review - Analyst Blog

AbbVie Focusing On Diversification Routes To Put Higher Sales Numbers On The Board

Today's Top Performers In Drugs

See More ABBV News...